An Open Label Study to Evaluate Cycle Control With Ortho Tri-Cyclen Lo (Norgestimate/Ethinyl Estradiol) and Yaz (Drospirenone/Ethinyl Estradiol) in Healthy Sexually Active Females.
Phase of Trial: Phase IV
Latest Information Update: 09 Jun 2011
At a glance
- Drugs Ethinylestradiol/norgestimate (Primary) ; Drospirenone/ethinylestradiol
- Indications Pregnancy
- Focus Pharmacodynamics
- 01 Dec 2009 Primary endpoint 'Menstrual bleeding' has been met.
- 01 Dec 2009 Results published in Obstetrics and Gynecology.
- 06 May 2009 Results presented at ACOG 2009.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History